Form D · Other Technology
Toro Neurovascular, Inc.
Irvine, CA · CIK 0002029796
Offering snapshot reported Jul 30, 2024 · SEC filing
- Reported sold
- $3.02M Offering amount: $3.52M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Mar 27, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2024 | Initial | $3,020,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-520054
Source: Form D, filed Jul 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hyung Posalit | Director, Executive |
| Ryan Walker | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
470 Wald
Irvine, CA, 92618
Irvine, CA, 92618